Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
Clinical trial NCT04636697 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04636697
- Sponsor
- Medicago
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2021-08-25
- Enrollment
- 30918
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.